The Effect on Serum Myeloperoxidase Activity and Oxidative Status of Eradication Treatment in Patients Helicobacter Pylori Infected

dc.contributor.author Nazligul, Yasar
dc.contributor.author Aslan, Mehmet
dc.contributor.author Horoz, Mehmet
dc.contributor.author Celik, Yilmaz
dc.contributor.author Dulger, Ahmet Cumhur
dc.contributor.author Celik, Hakim
dc.contributor.author Erel, Ozcan
dc.date.accessioned 2025-05-10T16:49:36Z
dc.date.available 2025-05-10T16:49:36Z
dc.date.issued 2011
dc.description.abstract Objectives: Myeloperoxidase activity has been investigated after eradication of Helicobacter pylon (H. pylori) in infected patients in previous studies but the results are controversial. The aim of this study was to investigate effect on serum myeloperoxidase activity and oxidative status of eradication treatment in H. pylon-infected patients. Design and methods: Gastric biopsy specimens were obtained from 30 H. pylori infected patients. Serum Myeloperoxidase activity was measured by enzyme-linked immunoassay. Oxidative status was determined using total antioxidant capacity (TAC) and total oxidant status (TOS) measurement and calculation of oxidative stress index (OSI). Results: After 2 weeks of the eradication treatment, serum myeloperoxidase activity, TOS and OSI values were significantly lower (all: p<0.001), while TAC was significantly higher (p<0.001). Conclusions: Our results indicate that eradication treatment in H. pylori-infected patients may affect both oxidative stress and myeloperoxidase activity which is an important biomarker in pathogenesis of atherosclerosis. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. en_US
dc.identifier.doi 10.1016/j.clinbiochem.2011.03.001
dc.identifier.issn 0009-9120
dc.identifier.issn 1873-2933
dc.identifier.scopus 2-s2.0-79955867090
dc.identifier.uri https://doi.org/10.1016/j.clinbiochem.2011.03.001
dc.identifier.uri https://hdl.handle.net/20.500.14720/1894
dc.language.iso en en_US
dc.publisher Pergamon-elsevier Science Ltd en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Helicobacter Pylori en_US
dc.subject Total Antioxidant Capacity en_US
dc.subject Total Oxidant Status en_US
dc.subject Oxidative Stress Index en_US
dc.subject Myeloperoxidase Activity en_US
dc.title The Effect on Serum Myeloperoxidase Activity and Oxidative Status of Eradication Treatment in Patients Helicobacter Pylori Infected en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 6603332467
gdc.author.scopusid 7006409671
gdc.author.scopusid 55924682900
gdc.author.scopusid 53463114900
gdc.author.scopusid 36476941100
gdc.author.scopusid 9273761900
gdc.author.scopusid 9273761900
gdc.author.wosid Erel, Ozcan/U-1008-2019
gdc.author.wosid Horoz, Mehmet/Aah-8361-2019
gdc.author.wosid Celik, Hakim/A-1789-2016
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Aslan, Mehmet] Ozel Ercis Capa Med Ctr, Internal Med Clin, TR-65000 Ercis, Van, Turkey; [Nazligul, Yasar] Kecioren Res Hosp, Dept Gastroenterol, Ankara, Turkey; [Horoz, Mehmet] Harran Univ, Fac Med, Dept Internal Med, Sanliurfa, Turkey; [Celik, Yilmaz; Dulger, Ahmet Cumhur] Yuzuncu Yil Univ, Fac Med, Dept Gastroenterol, Van, Turkey; [Celik, Hakim; Erel, Ozcan] Harran Univ, Fac Med, Dept Clin Biochem, Sanliurfa, Turkey en_US
gdc.description.endpage 649 en_US
gdc.description.issue 8-9 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 647 en_US
gdc.description.volume 44 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 21396358
gdc.identifier.wos WOS:000291081400014
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files